Thompson, E., Ashley, D., Ayasoufi, K., Norberg, P., Archer, G., Buckley, E., … Landi, D. (2024). CTIM-01. OUTCOMES AND IMMUNE RESPONSES AFTER PEPTIDE VACCINATION TARGETING HUMAN CYTOMEGALOVIRUS ANTIGEN PP65 IN CHILDREN AND YOUNG ADULTS WITH RECURRENT HIGH-GRADE GLIOMA AND MEDULLOBLASTOMA: RESULTS OF A PHASE 1 TRIAL. In Neuro-Oncology (Vol. 26, pp. viii84–viii84). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noae165.0335

Thompson, Eric, David Ashley, Kathy Ayasoufi, Pam Norberg, Gerald Archer, Evan Buckley, James Herndon, et al. “CTIM-01. OUTCOMES AND IMMUNE RESPONSES AFTER PEPTIDE VACCINATION TARGETING HUMAN CYTOMEGALOVIRUS ANTIGEN PP65 IN CHILDREN AND YOUNG ADULTS WITH RECURRENT HIGH-GRADE GLIOMA AND MEDULLOBLASTOMA: RESULTS OF A PHASE 1 TRIAL.” In Neuro-Oncology, 26:viii84–viii84. Oxford University Press (OUP), 2024. https://doi.org/10.1093/neuonc/noae165.0335.

Thompson E, Ashley D, Ayasoufi K, Norberg P, Archer G, Buckley E, et al. CTIM-01. OUTCOMES AND IMMUNE RESPONSES AFTER PEPTIDE VACCINATION TARGETING HUMAN CYTOMEGALOVIRUS ANTIGEN PP65 IN CHILDREN AND YOUNG ADULTS WITH RECURRENT HIGH-GRADE GLIOMA AND MEDULLOBLASTOMA: RESULTS OF A PHASE 1 TRIAL. In: Neuro-Oncology. Oxford University Press (OUP); 2024. p. viii84–viii84.

Thompson, Eric, et al. “CTIM-01. OUTCOMES AND IMMUNE RESPONSES AFTER PEPTIDE VACCINATION TARGETING HUMAN CYTOMEGALOVIRUS ANTIGEN PP65 IN CHILDREN AND YOUNG ADULTS WITH RECURRENT HIGH-GRADE GLIOMA AND MEDULLOBLASTOMA: RESULTS OF A PHASE 1 TRIAL.” Neuro-Oncology, vol. 26, no. Supplement_8, Oxford University Press (OUP), 2024, pp. viii84–viii84. Crossref, doi:10.1093/neuonc/noae165.0335.

Thompson E, Ashley D, Ayasoufi K, Norberg P, Archer G, Buckley E, Herndon J, Walter A, Archambault B, Balajonda B, Flahiff C, Jaggers D, Gorski L, Vlahovic G, Reap E, Schroeder K, Desjardins A, Johnson M, Peters K, Khasraw M, Mitchell D, Sampson J, Landi D. CTIM-01. OUTCOMES AND IMMUNE RESPONSES AFTER PEPTIDE VACCINATION TARGETING HUMAN CYTOMEGALOVIRUS ANTIGEN PP65 IN CHILDREN AND YOUNG ADULTS WITH RECURRENT HIGH-GRADE GLIOMA AND MEDULLOBLASTOMA: RESULTS OF A PHASE 1 TRIAL. Neuro-Oncology. Oxford University Press (OUP); 2024. p. viii84–viii84.